March 2027
CFP closes 14 Feb
International Conference on Advances in Cancer and Oncology Research
ICACOR 2027
International Conference on Advances in Cancer and Oncology Research is a 2-day event in Jeju Island, South Korea on 18–19 March 2027, organized by TheIIER Conferences. Abstracts are due by 14 February 2027. Its call for papers covers Cancer Biology and Molecular Oncology, Cancer Genetics, Genomics and Epigenetics and Tumor Microenvironment and Cancer Progression, among other areas. TheIIER Conferences has 13 other upcoming conferences listed here.
Important dates
-
Abstract / full paper deadline
In 90 days
-
Conference
Jeju Island, South Korea
All deadlines are as published by the organizer. Check the official website for the time zone.
About this conference
The upcoming international conference will address significant developments in cancer and oncology research, presenting an opportunity for experts to connect and share insights. The agenda will feature a wide range of topics, including the exploration of novel cancer treatment options, the integration of technology in patient care, and advancements in screening and prevention strategies. Participants are invited to submit their research findings, which may take the form of papers, abstracts, or posters for review. Accepted submissions will contribute to a collaborative publication. This event serves as a platform for networking among fellow researchers and practitioners, providing an avenue to discuss innovative approaches and challenges within the field. For registration and submission details, please refer to the conference's information page.
Topics and scope
- Cancer Biology and Molecular Oncology
- Cancer Genetics, Genomics and Epigenetics
- Tumor Microenvironment and Cancer Progression
- Cancer Stem Cells and Tumor Heterogeneity
- Cancer Biomarkers and Early Detection
- Cancer Screening, Diagnosis and Prevention
- Precision and Personalized Oncology
- Immuno-Oncology and Cancer Immunotherapy
- CAR-T Cell and Cell-Based Cancer Therapies
- Cancer Vaccines and Emerging Immunotherapies
- Targeted Cancer Therapies
- Novel Anticancer Drug Discovery and Development
- Chemotherapy and Drug Resistance
- Radiation Oncology and Advanced Radiotherapy
- Surgical Oncology and Minimally Invasive Cancer Surgery
- Medical Oncology and Clinical Oncology
- Pediatric and Adolescent Oncology
- Neuro-Oncology and Brain Tumors
- Breast, Lung, Colorectal and Gastrointestinal Cancers
- Gynecologic and Genitourinary Oncology
- Hematologic Malignancies and Hemato-Oncology
- Cancer Metastasis and Recurrence
- Liquid Biopsy and Circulating Tumor DNA
- Cancer Pathology and Molecular Diagnostics
- Cancer Imaging and Radiology Innovations
- Artificial Intelligence and Machine Learning in Oncology
- Bioinformatics and Computational Cancer Research
- Nanotechnology and Nanomedicine in Cancer Treatment
- Cancer Pharmacology and Therapeutics
- Clinical Trials and Translational Cancer Research
- Cancer Epidemiology and Public Health
- Environmental and Lifestyle Risk Factors
- Cancer Prevention and Risk Reduction
- Cancer Survivorship and Rehabilitation
- Palliative and Supportive Cancer Care
- Oncology Nursing and Allied Health
- Cancer Pain Management and Quality of Life
- Global Oncology, Healthcare Access and Health Equity
- Emerging Technologies and Future Directions in Oncology
Call for papers
Abstracts are due by 14 February 2027. Submission details are on the official website.
Where this information comes from
- Source
- Submitted by the organizer
- Listed on
- 2 November 2026
- Verification
- Reviewed by an editor before publishing
- Reference
- FCA2924981
Questions about ICACOR 2027
When and where is ICACOR 2027?
18–19 March 2027 in Jeju Island, South Korea.
Can I attend online?
This listing does not confirm an online option. Check the official website.
What is the submission deadline?
Abstracts are due by 14 February 2027.
How do I register?
Registration and fees are handled by the organizer on the official website.
Verify that you represent this event.
Tell us what needs to be reviewed.